Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy.
暂无分享,去创建一个
Rosario Palacios | Jesús Santos | Mercedes González | Josefa Ruiz | Pedro Valdivielso | Manuel Márquez | Pedro González-Santos | Jesús Santos | R. Palacios | M. Márquez | P. González-Sántos | P. Valdivielso | M. González | J. Ruiz
[1] G. Stajich,et al. Safety and Efficacy of HMG‐CoA Reductase Inhibitors for Treatment of Hyperlipidemia in Patients with HIV Infection , 2000, Pharmacotherapy.
[2] W. Castelli. Lipids, risk factors and ischaemic heart disease. , 1996, Atherosclerosis.
[3] S. Penzak,et al. Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. , 2000, Scandinavian journal of infectious diseases.
[4] D. Cooper,et al. Adverse effects of antiretroviral therapy , 2000, The Lancet.
[5] R. Knopp. Drug treatment of lipid disorders. , 1999, The New England journal of medicine.
[6] J. Murillas,et al. Atorvastatin for protease inhibitor-related hyperlipidaemia. , 1999, AIDS.
[7] David A. Cooper,et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors , 1998, AIDS.
[8] C. Fichtenbaum,et al. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 , 2002, AIDS.
[9] P. Hsyu,et al. Pharmacokinetic Interactions between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Simvastatin , 2001, Antimicrobial Agents and Chemotherapy.
[10] M. Eriksson,et al. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection , 2000, International journal of STD & AIDS.
[11] Spósito,et al. The Lipoprotein Profile in HIV Infected Patients. , 1997, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[12] K. Henry,et al. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities , 1998, The Lancet.
[13] R. Herman,et al. Drug interactions and the statins. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.